• $15.3M
    Market Cap
  • -68.71%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
2.9M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
2.3M
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
592,905
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
18.9M
N/A
N/A
N/A
1.8M
+5,073.22%
35,388
N/A
Research and Development Expense
-318,446
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
7,269
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
18.9M
+437.06%
3.5M
+92.52%
1.8M
+5,073.22%
35,388
N/A
Operating Profit
-18.3M
+420.24%
-3.5M
-972.89%
403,780
+1,241.01%
-35,388
N/A
Interest Income
63,883
+2,829.07%
2,181
-99.92%
2.8M
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
63,883
+2,829.07%
2,181
-99.92%
2.8M
N/A
0
N/A
Total Nonoperating Income and Expense
4.3M
+207.64%
1.4M
-49.22%
2.8M
N/A
N/A
N/A
Income before Taxes
-28.9M
+1,265.78%
-2.1M
-323.92%
944,591
+2,769.24%
-35,388
N/A
Income Taxes
-1.8M
-718.75%
295,728
-45.32%
540,811
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-27.1M
+1,022.35%
-2.4M
-697.08%
403,780
+1,241.01%
-35,388
N/A
Net Income from Continuing Operations Applicable to Common
-18.0M
+751.52%
-2.1M
+15.54%
-1.8M
+5,073.22%
-35,388
N/A
Basic EPS and Net Income
-0.92
+70.37%
-0.54
-1,180.00%
0.05
+600.00%
-0.01
N/A
Diluted EPS and Net Income
-0.92
+70.37%
-0.54
-1,180.00%
0.05
+600.00%
-0.01
N/A
Basic Weighted Average Shares
19.5M
+335.44%
4.5M
-41.71%
7.7M
+412.55%
1.5M
N/A
Diluted Weighted Average Shares
22.6M
+403.39%
4.5M
-41.94%
7.7M
+414.65%
1.5M
N/A
Balance Sheet
Cash and Cash Equivalents
1.7M
+2,470.91%
66,135
+328.92%
15,419
-87.62%
124,501
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
1.7M
+2,470.91%
66,135
+328.92%
15,419
-87.62%
124,501
N/A
Total Current Assets
2.8M
+518.54%
455,398
+1,912.63%
22,627
-81.83%
124,501
N/A
Accumulated Depreciation
291,099
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
169,130
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
169,130
-90.85%
1.8M
-95.10%
37.7M
+3,323.65%
1.1M
N/A
Total Assets
171.2M
+7,335.31%
2.3M
-93.71%
36.6M
+2,887.94%
1.2M
N/A
Income Taxes Payable
27.5M
+2,188.80%
1.2M
+35.87%
884,519
+5,103.05%
17,000
N/A
Total Short-Term Debt
2.3M
-9.35%
2.6M
N/A
0
-100.00%
1.2M
N/A
Total Current Liabilities
17.2M
+155.48%
6.7M
+229.63%
2.0M
+61.34%
1.3M
N/A
Total Long-Term Debt
5.2M
+6,876.92%
75,000
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
1,697
-99.92%
2.1M
0.00%
2.1M
+16,644.86%
12,362
N/A
Total Liabilities
44.2M
+402.92%
8.8M
+113.93%
4.1M
+225.19%
1.3M
N/A
Retained Earnings
-37.2M
+346.02%
-8.3M
+113.30%
-3.9M
+6,150.41%
-62,508
N/A
Total Stockholders Equity
127.0M
+1,624.43%
-8.3M
+113.31%
-3.9M
+10,315.89%
-37,508
N/A
Total Shares Outstanding
26.6M
+45,900.19%
57,821
-98.32%
3.4M
+98.96%
1.7M
N/A
Cash Flow
Cash from Operating Activities
-4.3M
+97.81%
-2.2M
+167.22%
-818,766
+19,233.32%
-4,235
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-2.6M
-107.36%
35.9M
+206.14%
-33.8M
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
8.4M
+124.85%
-33.7M
-197.48%
34.5M
+27,759.15%
123,979
N/A
Financials Ratio
Gross Margin
20.40%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-631.01%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-31.18%
+151.78%
-12.39%
-680.55%
2.13%
N/A
N/A
N/A
Return on Equity
-45.59%
-215.73%
39.39%
+292.40%
-20.47%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.16
+142.04%
0.07
+510.81%
0.01
N/A
N/A
N/A
Cash Ratio
0.10
+911.22%
0.010
+28.95%
0.008
N/A
N/A
N/A
Debt-to-Equity Ratio
0.06
+118.79%
-0.32
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.04
-96.15%
1.15
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow